BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16135370)

  • 1. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
    Simon L; Loney NW
    Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfacial kinetics effects on transdermal drug delivery: a computer modeling.
    Xing MM; Pan N; Zhong W; Hui X; Maibach HI
    Skin Res Technol; 2008 May; 14(2):165-72. PubMed ID: 18412558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finite dose percutaneous drug absorption: theory and its application to in vitro timolol permeation.
    Kubota K; Yamada T
    J Pharm Sci; 1990 Nov; 79(11):1015-9. PubMed ID: 2292763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A random walk method for percutaneous drug absorption pharmacokinetics: application to repeated administration of a therapeutic timolol patch.
    Kubota K; Koyama E; Yasuda K
    J Pharm Sci; 1991 Aug; 80(8):752-6. PubMed ID: 1791535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-dimensional mathematical model of percutaneous drug absorption.
    George K; Kubota K; Twizell EH
    Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
    Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
    Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
    Soni S; Dixit VK
    Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
    [No Abstract]   [Full Text] [Related]  

  • 11. A two-phase two-layer model for transdermal drug delivery and percutaneous absorption.
    Pontrelli G; de Monte F
    Math Biosci; 2014 Nov; 257():96-103. PubMed ID: 24835077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of timolol by electroporation through human skin.
    Denet AR; Préat V
    J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diffusion-diffusion model for percutaneous drug absorption.
    Kubota K; Ishizaki T
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):409-39. PubMed ID: 3772740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of diffusion with partitioning in stratum corneum using a finite element model.
    Barbero AM; Frasch HF
    Ann Biomed Eng; 2005 Sep; 33(9):1281-92. PubMed ID: 16133933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finite element modeling of coupled diffusion with partitioning in transdermal drug delivery.
    Rim JE; Pinsky PM; van Osdol WW
    Ann Biomed Eng; 2005 Oct; 33(10):1422-38. PubMed ID: 16240090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental verification of the mechanistic model for transdermal transport including iontophoresis.
    Hirvonen J; Murtomäki L; Kontturi K
    J Control Release; 1998 Dec; 56(1-3):169-74. PubMed ID: 9801440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
    Fatouros DG; Bouwstra JA
    J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels.
    Wei G; Ding PT; Zheng JM; Lu WY
    Biomed Chromatogr; 2006 Jan; 20(1):67-71. PubMed ID: 15954162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin.
    Cevc G; Vierl U
    J Control Release; 2007 Mar; 118(1):18-26. PubMed ID: 17254662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.